Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
IGC Pharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IGC
American
8731
https://igcpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for IGC Pharma Inc
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
- Apr 16th, 2024 11:00 am
IGC Pharma Adds Advisor in Artificial Intelligence
- Apr 9th, 2024 1:00 pm
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
- Mar 26th, 2024 7:00 pm
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
- Mar 20th, 2024 3:00 pm
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
- Mar 20th, 2024 11:00 am
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
- Mar 12th, 2024 7:00 pm
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
- Feb 28th, 2024 6:00 pm
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target
- Feb 23rd, 2024 5:01 pm
IGC Pharma Reports Third Quarter Fiscal 2024 Results
- Feb 17th, 2024 12:05 am
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
- Feb 1st, 2024 2:20 pm
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s
- Jan 23rd, 2024 2:20 pm
IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial
- Jan 17th, 2024 2:20 pm
Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s
- Dec 19th, 2023 2:20 pm
IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
- Dec 13th, 2023 2:30 pm
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
- Dec 6th, 2023 1:30 pm
IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
- Nov 21st, 2023 1:30 pm
IGC Pharma Reports Second Quarter Fiscal 2024 Results
- Nov 13th, 2023 1:00 pm
IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy
- Oct 19th, 2023 7:30 pm
IGC Announces Results of its 2023 Annual Stockholders Meeting
- Aug 21st, 2023 6:30 pm
IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials
- Aug 14th, 2023 12:30 pm
Scroll